NCT01648127View on ClinicalTrials.gov

Pharmacokinetics of Ceftaroline in Normal and Obese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Drug Safety

Interventions

DRUG

Ceftaroline

A single dose of ceftaroline fosamil 600 mg as a 1-hour continuous intravenous infusion

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Keith A. Rodvold

OTHER